Online citations, reference lists, and bibliographies.
← Back to Search

Evaluation Of Warfarin Initiation Regimens In Elderly Inpatients

M. O'Connell, P. Kowal, C. J. Allivato, T. Repka
Published 2000 · Medicine

Save to my Library
Download PDF
Analyze on Scholarcy Visualize in Litmaps
Share
Reduce the time it takes to create your bibliography by a factor of 10 by using the world’s favourite reference manager
Time to take this seriously.
Get Citationsy
Study Objective. To compare initial warfarin doses of 5 mg or below and doses above 5 mg in hospitalized elderly.
This paper references
10.1111/J.1365-2125.1975.TB00474.X
Changes in drug metabolism with increasing age: 1. warfarin binding and plasma proteins.
M. Hayes (1975)
The effect of age on the sensitivity to warfarin sodium
D. Hewick (1975)
10.1111/J.1365-2125.1977.TB00719.X
Age as a determinant of sensitivity to warfarin.
A. Shepherd (1977)
10.1111/j.1440-1681.1978.tb00664.x
WARFARIN SODIUM: STEADY‐STATE PLASMA LEVELS AND PATIENT AGE
K. Hotraphinyo (1978)
10.1136/bmj.288.6426.1268
Flexible induction dose regimen for warfarin and prediction of maintenance dose.
A. Fennerty (1984)
10.1093/AGEING/17.6.388
Long-term oral anticoagulant therapy in elderly patients.
L. S. Wickramasinghe (1988)
10.1093/AGEING/20.3.217
The association of age with dosage requirement for warfarin.
M. Redwood (1991)
10.1111/J.1445-5994.1991.TB04697.X
Standardised initial warfarin treatment: evaluation of initial treatment response and maintenance dose prediction by randomised trial, and risk factors for an excessive warfarin response.
C. J. Doecke (1991)
10.7326/0003-4819-116-11-901
Aging and the anticoagulant response to warfarin therapy.
J. Gurwitz (1992)
Initial warfarin treatment in hospital--room for less caution? A twelve month prospective audit.
T. Wilkinson (1992)
Third consensus conference on antithrombotic therapy
MA Crowther (1992)
10.1016/0002-9343(93)90285-W
Anticoagulant-related bleeding: clinical epidemiology, prediction, and prevention.
C. Landefeld (1993)
10.7326/0003-4819-120-11-199406010-00001
Risk Factors for Intracranial Hemorrhage in Outpatients Taking Warfarin
E. Hylek (1994)
10.1007/BF03257457
Erratum to Anticoagulants in older patients: a safety perspective
R. Beyth (1995)
10.2165/00002512-199506010-00004
Anticoagulants in Older Patients
R. Beyth (1995)
10.4065/70.8.725
Bleeding and thromboembolism during anticoagulant therapy: a population-based study in Rochester, Minnesota.
M. Gitter (1995)
10.1136/pgmj.71.833.153
Effect of age upon the induction and maintenance of anticoagulation with warfarin.
J. Gladman (1995)
Anticoagulants in older patients—a safety perspective. Drugs Aging 1995;6:45–54
RJ Beyth (1995)
10.1111/j.1532-5415.1996.tb02949.x
The Use Of Oral Anticoagulants (Warfarin) in Older People
(1996)
10.7326/0003-4819-124-11-199606010-00004
The Risk for and Severity of Bleeding Complications in Elderly Patients Treated with Warfarin
Stephan Fihn (1996)
10.1016/S0140-6736(96)01109-9
Bleeding complications of oral anticoagulant treatment: an inception-cohort, prospective collaborative study (ISCOAT)
G. Palareti (1996)
WARFARIN : LESS MAY BE BETTER. AUTHORS' REPLY
M. Adelman (1997)
10.7326/0003-4819-127-4-199708150-00019
Reply: Warfarin: Less May Be Better
M. Crowther (1997)
10.7326/0003-4819-126-2-199701150-00006
Comparison of 5-mg and 10-mg Loading Doses in Initiation of Warfarin Therapy
L. Harrison (1997)
10.1046/j.1365-2141.1998.00716.x
A warfarin induction regimen for out‐patient anticoagulation in patients with atrial fibrillation
Tait (1998)
10.1016/S0002-9343(98)00198-3
Prospective evaluation of an index for predicting the risk of major bleeding in outpatients treated with warfarin.
R. Beyth (1998)
10.1001/ARCHINTE.159.1.46
A randomized trial comparing 5-mg and 10-mg warfarin loading doses.
M. Crowther (1999)
10.1111/J.1445-5994.1999.TB01623.X
Comparison of an age adjusted warfarin loading protocol with empirical dosing and Fennerty's protocol.
G. Roberts (1999)
10.1093/AGEING/29.1.31
A comparison of a low-dose warfarin induction regimen with the modified Fennerty regimen in elderly inpatients.
J. Gedge (2000)
A comparison of a low-dose warfarin induction regimen with the modified Fennerty regimen in elderly inpatients. Age Ageing 2000;29:31–4
J Gedge (2000)
10.1378/CHEST.119.1_SUPPL.8S
Oral anticoagulants: mechanism of action, clinical effectiveness, and optimal therapeutic range.
J. Hirsh (2001)



This paper is referenced by
New potentiometric membrane sensor determination of warfarin sodium in pharmaceutical samples
Y. T. Kamal (2015)
Effects of Diuretics on Warfarin Responses in Patients with Atrial Fibrillation
Hee Joo Park (2013)
Enquête sur la qualité du suivi ambulatoire des anticoagulantsoraux chez les patients de plus de 75 ans
A. Monti (2012)
Thrombosis , 9 th Oral Anticoagulant Therapy : Antithrombotic
W. Ageno (2012)
10.1007/BF03256232
The Influence of NSAIDs on Coumarin Sensitivity in Patients with CYP2C9 Polymorphism After Total Hip Replacement Surgery
M. Beinema (2012)
10.1378/chest.11-2293
Antiplatelet drugs: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.
J. Eikelboom (2012)
ANTITHROMBOTIC THERAPY AND PREVENTION OF THROMBOSIS, 9TH ED: ACCP GUIDELINES
G. Guyatt (2012)
10.1378/chest.11-2286
Introduction to the ninth edition: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.
G. Guyatt (2012)
10.1378/chest.11-2292
Oral anticoagulant therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.
W. Ageno (2012)
Evidence-Based Clinical Practice Guidelines ed: American College of Chest Physicians Therapy and Prevention of Thrombosis, 9th Oral Anticoagulant Therapy : Antithrombotic
E. Hylek (2012)
Farmacogenética da varfarina : proposta de um algoritmo para a predição de dose
M. R. Botton (2010)
10.1177/0897190010362177
Patient Factors That Influence Warfarin Dose Response
P. White (2010)
10.1016/j.jacc.2010.04.063
Antithrombotic therapy in the elderly.
D. Capodanno (2010)
10.1016/j.bcmd.2010.03.006
Warfarin maintenance dose in older patients: higher average dose and wider dose frequency distribution in patients of African ancestry than those of European ancestry.
Candice L Garwood (2010)
10.1007/s00228-010-0857-7
Pharmacogenetic testing and therapeutic drug monitoring are complementary tools for optimal individualization of drug therapy
G. Gervasini (2010)
10.1016/j.hoc.2010.05.010
Optimizing use of current anticoagulants.
D. Witt (2010)
10.1016/j.thromres.2008.12.001
A 10 mg warfarin initiation nomogram is safe and effective in outpatients starting oral anticoagulant therapy for venous thromboembolism.
K. Monkman (2009)
10.1007/978-1-60327-362-6_22
Drug–Nutrient Interactions in the Elderly
B. Kinosian (2009)
10.1378/chest.08-0670
Pharmacology and management of the vitamin K antagonists: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).
J. Ansell (2008)
10.1016/j.cll.2008.10.002
Dynamic pharmacogenetic models in anticoagulation therapy.
M. Bon Homme (2008)
10.1016/j.ccl.2007.12.006
Anticoagulant treatment of deep vein thrombosis and pulmonary embolism.
H. Tran (2008)
Practice Guidelines (8th Edition) Chest Physicians Evidence-Based Clinical Vitamin K Antagonists: American College of Pharmacology and Management of the
G. Palareti (2008)
10.1345/aph.1L098
Delivery of Optimized Anticoagulant Therapy: Consensus Statement from the Anticoagulation Forum
D. Garcia (2008)
10.1007/s11239-007-0104-y
Pharmacogenetics of warfarin: regulatory, scientific, and clinical issues
B. Gage (2007)
10.2217/14796678.3.3.321
Vitamin K antagonist use in the elderly: special considerations.
V. Siguret (2007)
10.2165/00002512-200623010-00002
Haemorrhagic Complications of Vitamin K Antagonists in the Elderly
É. Pautas (2006)
10.1182/ASHEDUCATION-2006.1.467
Pharmacogenetics-based coumarin therapy.
B. Gage (2006)
10.1016/J.CGER.2005.09.004
Anticoagulant treatment of deep vein thrombosis and pulmonary embolism.
H. Tran (2006)
10.7326/0003-4819-140-6-200403160-00029
Randomized Trial of Warfarin Nomograms
R. Didomenico (2004)
10.1108/NFS.2011.41.6.448.1
Handbook of drug-nutrient interactions.
J. Boullata (2004)
10.1023/B:THRO.0000014598.24114.62
Pharmacogenetics and Anticoagulant Therapy
B. Gage (2004)
10.1378/CHEST.126.3_SUPPL.204S
The pharmacology and management of the vitamin K antagonists: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.
J. Ansell (2004)
See more
Semantic Scholar Logo Some data provided by SemanticScholar